Chargement en cours…

Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional

This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry.  It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These ap...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Auteur principal: Huml, Raymond A. (Auteur)
Collectivité auteur: SpringerLink (Online service)
Format: Électronique eBook
Langue:Inglés
Publié: New York, NY : Springer New York : Imprint: Springer, 2012.
Édition:1st ed. 2012.
Collection:SpringerBriefs in Pharmaceutical Science & Drug Development,
Sujets:
Accès en ligne:Texto Completo

Documents similaires